Abbott | ABT

Abbott traded at $99.08 this Friday March 31st, increasing $0.46 or 0.47 percent since the previous trading session. Looking back, over the last four weeks, Abbott gained 1.74 percent. Over the last 12 months, its price fell by 16.44 percent. Looking ahead, we forecast Abbott to be priced at 94.95 by the end of this quarter and at 86.18 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
99.08
Daily Change
0.47%
Yearly
-16.44%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Peers Price Day Year
Terumo 3,574.00 87.00 2.50% -4.67%
Agilent 134.49 0.64 0.48% 1.63%
Abbott 99.08 0.46 0.47% -16.44%
AtriCure 41.16 0.29 0.71% -37.32%
Baxter International 40.31 -0.23 -0.57% -48.01%
Becton, Dickinson and Co. 245.17 2.24 0.92% -6.60%
Bio-Rad Laboratories 471.78 -0.19 -0.04% -16.24%
Boston Scientific 49.60 0.52 1.06% 11.99%
Cooper Companies 367.47 5.65 1.56% -12.00%
Cardiovascular Systems 19.86 0.02 0.10% -12.12%
Danaher 249.80 2.32 0.94% -14.36%
Dexcom 114.40 0.44 0.39% -10.56%
Edwards Lifesciences 81.57 -0.07 -0.09% -30.71%
Globus Medical 55.72 2.25 4.21% -24.48%
Hologic 80.50 1.30 1.64% 4.79%
Integra LifeSciences 56.52 1.08 1.95% -12.04%
Intuitive Surgical 251.30 0.54 0.22% -17.75%
J&J 153.43 0.12 0.08% -13.43%
Masimo 178.54 2.25 1.28% 22.67%
Medtronic 79.18 0.11 0.14% -29.63%
Merit Medical Systems 72.97 0.55 0.76% 9.70%
NuVasive 40.64 2.27 5.92% -28.32%
Pfizer 40.38 0.13 0.32% -22.00%
Insulet 316.88 3.98 1.27% 18.95%
Smith & Nephew PLC 1,109.81 7.31 0.66% -8.58%
Stryker 280.71 1.68 0.60% 4.33%
Teleflex 248.95 2.62 1.06% -29.84%
Thermo Fisher Scientific 562.97 7.82 1.41% -4.96%
Tandem Diabetes Care 39.93 1.17 3.02% -65.66%
Zimmer Biomet Holdings Inc 126.76 0.02 0.02% -0.89%

Indexes Price Day Year
US500 4059 23.02 0.57% -10.71%

Abbott
Abbott Laboratories (Abbott) is engaged in the discovery, development, manufacture, and sale of a diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Its products include a line of rhythm management, electrophysiology, heart failure, vascular and structural heart devices for the treatment of cardiovascular diseases, and diabetes care products for people with diabetes, as well as neuromodulation devices for the management of chronic pain and movement disorders. The Company’s products are sold directly to wholesalers, distributors, government agencies, health care facilities, pharmacies, and independent retailers from Abbott-owned distribution centers and public warehouses. It offers cardiovascular and metabolic products, including Lipanthyl, TriCor, Teveten, Teveten Plus, Physiotens, and Synthroid.